Title : Phase 1 study of lenalidomide plus dose-adjusted EPOCH-R in patients with aggressive B-cell lymphomas with deregulated MYC and BCL2.

Pub. Date : 2019 Jun 1

PMID : 30707764






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Phase 1 study of lenalidomide plus dose-adjusted EPOCH-R in patients with aggressive B-cell lymphomas with deregulated MYC and BCL2. Lenalidomide BCL2 apoptosis regulator Homo sapiens